Rejuvenate Biomed is a science based healthy aging company developing prescription drugs in healthy aging by repositioning approved drugs.
Rejuvenate Boimed has raised €16M across 1 funding round from 2 investors, most recently a Series B round in Oct 2021. Based in Heusden, Belgium; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-12 | Series B |
| €16M |
| Rejuveron,Vesalius Biocapital Partners |
| View deal → |
